Endoscopic Cryotherapy for the Treatment of Epistaxis Due to Hereditary Hemorrhagic Telangiectasia

被引:5
|
作者
Kim, Joo Yeon [1 ]
Oh, Jung Ho [1 ]
Kim, Geun Tae [2 ]
Kwon, Jae Hwan [1 ]
机构
[1] Kosin Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pusan 602702, South Korea
[2] Kosin Univ, Coll Med, Div Rheumatol, Pusan 602702, South Korea
关键词
Hereditary hemorrhagic telangiectasia; HHT; cryotherapy; POPULATION; MANAGEMENT;
D O I
10.1097/SCS.0000000000000453
中图分类号
R61 [外科手术学];
学科分类号
摘要
Hereditary hemorrhagic telangiectasia (HHT), an autosomal dominant vascular disease, involves mainly skin, mucocutaneous membranes, and viscera. Epistaxis is one of the most common symptoms of HHT, and chronic, frequently relapsing epistaxis can cause symptoms such as iron deficiency anemia, severe crusting, and nasal obstruction that can cause lower quality of life. Treatments for HHT range from medication and conservative management to more aggressive surgeries. None of the treatment options, however, have had satisfactory outcomes until now. We introduced cryotherapy for a patient with HHT and at least a 10-year history of frequent, severe epistaxis. This treatment strategy resulted in successful management of symptoms and no associated complications. We present herein a literature review and the clinical course and symptoms of an HHT patient who underwent cryotherapy.
引用
收藏
页码:E120 / E122
页数:3
相关论文
共 50 条
  • [41] Pazopanib in treatment of hereditary hemorrhagic telangiectasia-related epistaxis and gastrointestinal bleeding
    Lewandowska, Magdalena D.
    Gordon, Shelby
    Betbadal, Anthony
    Shapiro, Amy D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2025, 23 (02) : 525 - 530
  • [42] A NOVEL APPROACH TO THE TREATMENT OF SEVERE RECURRENT EPISTAXIS SECONDARY TO HEREDITARY HEMORRHAGIC TELANGIECTASIA
    Marle, A. L.
    Delmas, A. S.
    McGary, R. T.
    Moore, F. C.
    Muncy, L. E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 476 - 477
  • [43] Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review
    Halderman, Ashleigh A.
    Ryan, Matthew W.
    Clark, Christopher
    Sindwani, Raj
    Reh, Douglas D.
    Poetker, David M.
    Invernizzi, Rosangela
    Marple, Bradley F.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (06) : 713 - 728
  • [44] Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia
    Thompson, Andrew B.
    Ross, Douglas A.
    Berard, Paul
    Figueroa-Bodine, Jaszmin
    Livada, Nancy
    Richer, Sara L.
    ALLERGY & RHINOLOGY, 2014, 5 (02): : E91 - E95
  • [45] ENDOSCOPIC DIAGNOSIS OF HEREDITARY HEMORRHAGIC TELANGIECTASIA
    MAYER, IE
    HERSH, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1981, 3 (04) : 361 - 365
  • [46] The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab
    Alderman, Charles
    Corlett, Jonathan
    Cullis, Jonathan
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) : 547 - 548
  • [47] Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study
    Boyer, Holly
    Fernandes, Patricia
    Duran, Olga
    Hunter, David
    Goding, George
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2011, 1 (04) : 319 - 323
  • [48] Endovascular Management of Malignant Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia
    Vladev, G.
    Sirakov, A.
    Matanov, S.
    Sirakova, K.
    Ninov, K.
    Shakir, D.
    Sirakov, S.
    NEUROSONOLOGY AND CEREBRAL HEMODYNAMICS, 2024, 20 (02): : 119 - 126
  • [49] Pilot study of submucosal radiofrequency for epistaxis in hereditary hemorrhagic telangiectasia
    Mortuaire, G.
    Boute, O.
    Hatron, P. Y.
    Chevalier, D.
    RHINOLOGY, 2013, 51 (04) : 355 - 360
  • [50] Duration of effectiveness of coblation for recurrent epistaxis in hereditary hemorrhagic telangiectasia
    Feller, Christina N.
    Adams, Jazzmyne A.
    Friedland, David R.
    Poetker, David M.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (03)